Cormorant Asset Management as of June 30, 2023
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 62 positions in its portfolio as reported in the June 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Moonlake Immunotherapeutics Class A Ord (MLTX) | 23.3 | $415M | 8.1M | 51.00 | |
Ambrx Biopharma Sponsored Ads | 8.9 | $158M | 9.6M | 16.46 | |
Apellis Pharmaceuticals (APLS) | 6.9 | $123M | 1.3M | 91.10 | |
Bridgebio Pharma (BBIO) | 4.8 | $86M | 5.0M | 17.20 | |
Biomea Fusion (BMEA) | 4.4 | $78M | 3.6M | 21.95 | |
Arcellx Common Stock (ACLX) | 3.5 | $63M | 2.0M | 31.62 | |
Immuneering Corp Class A Com (IMRX) | 2.4 | $43M | 4.2M | 10.14 | |
Cymabay Therapeutics | 2.3 | $42M | 3.8M | 10.95 | |
Protagonist Therapeutics (PTGX) | 2.3 | $41M | 1.5M | 27.62 | |
Enliven Therapeutics (ELVN) | 2.2 | $40M | 1.9M | 20.41 | |
Vaxcyte (PCVX) | 1.9 | $33M | 665k | 49.94 | |
Design Therapeutics (DSGN) | 1.8 | $32M | 5.2M | 6.30 | |
Zentalis Pharmaceuticals (ZNTL) | 1.7 | $31M | 1.1M | 28.21 | |
Erasca (ERAS) | 1.7 | $30M | 11M | 2.76 | |
Avidity Biosciences Ord (RNA) | 1.6 | $29M | 2.6M | 11.09 | |
Cabaletta Bio (CABA) | 1.6 | $29M | 2.2M | 12.91 | |
Eyepoint Pharmaceuticals Com New (EYPT) | 1.6 | $28M | 3.2M | 8.70 | |
Olema Pharmaceuticals (OLMA) | 1.6 | $28M | 3.1M | 9.03 | |
Aerovate Therapeutics (AVTE) | 1.5 | $27M | 1.6M | 17.15 | |
Tarsus Pharmaceuticals (TARS) | 1.4 | $26M | 1.4M | 18.07 | |
89bio (ETNB) | 1.4 | $26M | 1.4M | 18.95 | |
Axsome Therapeutics (AXSM) | 1.4 | $24M | 340k | 71.86 | |
Structure Therapeutics Sponsored Ads (GPCR) | 1.3 | $24M | 576k | 41.57 | |
Edgewise Therapeutics (EWTX) | 1.3 | $23M | 2.9M | 7.75 | |
Miragen Therapeutics (VRDN) | 1.1 | $20M | 850k | 23.79 | |
Karuna Therapeutics Ord | 1.0 | $17M | 80k | 216.85 | |
Longboard Pharmaceuticals In (LBPH) | 1.0 | $17M | 2.4M | 7.34 | |
Rocket Pharmaceuticals (RCKT) | 1.0 | $17M | 869k | 19.87 | |
Axonics Modulation Technolog (AXNX) | 0.9 | $16M | 322k | 50.47 | |
Sarepta Therapeutics (SRPT) | 0.8 | $15M | 130k | 114.52 | |
Pharvaris N V (PHVS) | 0.8 | $15M | 974k | 15.14 | |
Ideaya Biosciences (IDYA) | 0.8 | $14M | 600k | 23.50 | |
Cogent Biosciences (COGT) | 0.7 | $12M | 1.0M | 11.84 | |
Iveric Bio Call Option | 0.7 | $12M | 300k | 39.34 | |
Stoke Therapeutics (STOK) | 0.6 | $12M | 1.1M | 10.63 | |
Praxis Precision Medicines I | 0.6 | $11M | 9.5M | 1.15 | |
Immunovant (IMVT) | 0.6 | $10M | 550k | 18.97 | |
Disc Medicine (IRON) | 0.6 | $10M | 225k | 44.40 | |
Rhythm Pharmaceuticals (RYTM) | 0.6 | $9.9M | 600k | 16.49 | |
Lianbio Sponsored Ads (LIANY) | 0.5 | $9.7M | 4.3M | 2.28 | |
Morphic Hldg (MORF) | 0.5 | $8.6M | 150k | 57.33 | |
Astria Therapeutics (ATXS) | 0.5 | $8.3M | 1.0M | 8.33 | |
Arcutis Biotherapeutics (ARQT) | 0.4 | $7.6M | 800k | 9.53 | |
Gh Research Ordinary Shares (GHRS) | 0.4 | $7.0M | 593k | 11.87 | |
Verve Therapeutics (VERV) | 0.4 | $6.6M | 350k | 18.75 | |
Rapt Therapeutics (RAPT) | 0.3 | $6.1M | 325k | 18.70 | |
Vigil Neuroscience (VIGL) | 0.3 | $5.8M | 617k | 9.40 | |
Atea Pharmaceuticals (AVIR) | 0.3 | $5.8M | 1.5M | 3.74 | |
Akero Therapeutics (AKRO) | 0.3 | $5.4M | 115k | 46.69 | |
Alx Oncology Hldgs (ALXO) | 0.3 | $4.6M | 612k | 7.51 | |
Bioatla (BCAB) | 0.2 | $3.5M | 1.2M | 3.00 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.2 | $3.5M | 562k | 6.19 | |
Leap Therapeutics Com New (LPTX) | 0.2 | $3.4M | 1.1M | 3.13 | |
Ocular Therapeutix (OCUL) | 0.2 | $3.3M | 645k | 5.16 | |
Greenlight Biosciencs Hlds P Common Stock | 0.2 | $2.7M | 9.2M | 0.30 | |
Galecto (GLTO) | 0.1 | $2.6M | 1.0M | 2.52 | |
Biohaven (BHVN) | 0.1 | $2.0M | 82k | 23.92 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $933k | 392k | 2.38 | |
Graphite Bio | 0.0 | $519k | 200k | 2.60 | |
Harpoon Therapeutics | 0.0 | $384k | 541k | 0.71 | |
Atreca Cl A Com (BCEL) | 0.0 | $313k | 319k | 0.98 | |
Orchard Therapeutics Spon Ads New | 0.0 | $134k | 26k | 5.21 |